Skip to content

Management of reduced and delayed menstrual flow with Ayurveda medicine

A Single Arm Clinical Trial to Evaluate the Artava Janaka properties of Kashmarya Kshudrasaha Granules in the Management of Vataja Artava Dushti W.S.R to Oligohypomenorrhoea - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072724
Enrollment
70
Registered
2024-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N913- Primary oligomenorrhea

Interventions

None listed

Sponsors

Meghna Vaman Nayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •All female patients in the Age group of 13-19 years who are willing to participate in the study who are having symptoms of vataja artava dushti. •With symptoms of oligo-hypomenorrhea i.e. inter-menstrual duration more than 35 days and menstrual bleeding flow less than 2 days. •Female patients irrespective of caste, education, income group and any occupation will be selected. •Hemoglobin 9 g % and above. •BMI – 18-27.

Exclusion criteria

Exclusion criteria: •K/C/O of any major systemic diseases. •K/H/O of Mullerian Duct Anomalies. •Intermenstrual duration more than 60 days.

Design outcomes

Primary

MeasureTime frame
Artava Janana Effect of kashmarya- kshudrasaha granules in vataja artava dushti W.S.R. to Oligo-hypomenorrhoea on the basis of Pictoral Blood Assessment Chart, artava srava swaroopa chart, artava srava kalaavdhi chart, duration between two artava darshana both before and after treatment.Timepoint: 3 menstrual cycles

Secondary

MeasureTime frame
Improvement in Vataja artava dushti condition i.e. improving the amount of menstrual bleeding & reducing the inter-menstrual duration.Timepoint: 3 menstrual cycles

Countries

India

Contacts

Public ContactVishala Turlapati

Yashwant Ayurvedic College, Post Graduate Training and Research Centre

meghnanayak1698@gmail.com9637066564

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026